These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of long-acting dual bronchodilator therapy on exercise tolerance, dynamic hyperinflation, and dead space during constant work rate exercise in COPD. Stringer WW; Porszasz J; Cao M; Rossiter HB; Siddiqui S; Rennard S; Casaburi R J Appl Physiol (1985); 2021 Jun; 130(6):2009-2018. PubMed ID: 33914661 [TBL] [Abstract][Full Text] [Related]
4. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959 [TBL] [Abstract][Full Text] [Related]
5. Effect of endurance training on expiratory flow limitation and dynamic hyperinflation in patients with stable chronic obstructive pulmonary disease. Chen R; Chen R; Chen X; Chen L Intern Med J; 2014 Aug; 44(8):791-800. PubMed ID: 24860934 [TBL] [Abstract][Full Text] [Related]
6. The effects of short recovery duration on VO2 and muscle deoxygenation during intermittent exercise. Belfry GR; Paterson DH; Murias JM; Thomas SG Eur J Appl Physiol; 2012 May; 112(5):1907-15. PubMed ID: 21927832 [TBL] [Abstract][Full Text] [Related]
13. Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease. Mainguy V; Girard D; Maltais F; Saey D; Milot J; Sénéchal M; Poirier P; Provencher S Am J Cardiol; 2012 Jul; 110(2):258-63. PubMed ID: 22497677 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181 [TBL] [Abstract][Full Text] [Related]
15. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial. Beeh KM; Watz H; Puente-Maestu L; de Teresa L; Jarreta D; Caracta C; Garcia Gil E; Magnussen H BMC Pulm Med; 2014 Dec; 14():209. PubMed ID: 25539654 [TBL] [Abstract][Full Text] [Related]
16. Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Elbehairy AF; O'Donnell CD; Abd Elhameed A; Vincent SG; Milne KM; James MD; Webb KA; Neder JA; O'Donnell DE; J Appl Physiol (1985); 2019 Oct; 127(4):1107-1116. PubMed ID: 31369329 [TBL] [Abstract][Full Text] [Related]
17. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease. Casaburi R; Maltais F; Porszasz J; Albers F; Deng Q; Iqbal A; Paden HA; O'Donnell DE; Ann Am Thorac Soc; 2014 Nov; 11(9):1351-61. PubMed ID: 25289942 [TBL] [Abstract][Full Text] [Related]
18. Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial. Beeh KM; Singh D; Di Scala L; Drollmann A Int J Chron Obstruct Pulmon Dis; 2012; 7():503-13. PubMed ID: 22973092 [TBL] [Abstract][Full Text] [Related]
19. Human skeletal muscle mitochondrial responses to single-leg intermittent or continuous cycle exercise training matched for absolute intensity and total work. Skelly LE; MacInnis MJ; Bostad W; McCarthy DG; Jenkins EM; Archila LR; Tarnopolsky MA; Gibala MJ Scand J Med Sci Sports; 2023 Jun; 33(6):872-881. PubMed ID: 36779702 [TBL] [Abstract][Full Text] [Related]
20. Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study. Beeh KM; Korn S; Beier J; Jadayel D; Henley M; D'Andrea P; Banerji D Respir Med; 2014 Apr; 108(4):584-92. PubMed ID: 24534204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]